Cumberland Pharmaceuticals Inc (CPIX)
US Market

Cumberland Pharmaceuticals (CPIX) Financial Statements


Cumberland Pharmaceuticals Financial Overview

Cumberland Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.124; its P/E ratio is -15.17; Cumberland Pharmaceuticals is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 10.89M$ 9.22M$ 9.12M$ 11.41M$ 10.30M
Gross Profit$ 9.37M$ 7.97M$ 6.47M$ 9.19M$ 8.27M
EBIT$ 1.06M$ 365.58K$ -2.28M$ -266.99K$ -1.22M
EBITDA$ 2.27M$ 1.63M$ -1.82M$ 1.28M$ 398.20K
Net Income Common Stockholders$ 872.20K$ 145.12K$ -3.41M$ -408.64K$ -1.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.25M$ 16.39M$ 19.76M$ 19.54M$ 18.22M
Total Assets$ 89.38M$ 89.47M$ 92.93M$ 90.78M$ 92.52M
Total Debt$ 18.95M$ 20.78M$ 20.96M$ 17.93M$ 19.51M
Net Debt$ 696.92K$ 4.39M$ 1.20M$ -1.61M$ 1.30M
Total Liabilities$ 52.54M$ 53.42M$ 56.95M$ 52.29M$ 53.31M
Stockholders Equity$ 37.16M$ 36.36M$ 36.27M$ 38.76M$ 39.46M
Cash Flow-
Free Cash Flow$ 5.30M$ -1.28M$ 2.00M$ 2.42M$ 2.16M
Operating Cash Flow$ 5.40M$ -1.10M$ 3.64M$ 2.64M$ 2.33M
Investing Cash Flow$ -305.78K$ -442.09K$ -640.77K$ 680.80K$ -172.59K
Financing Cash Flow$ -3.28M$ -1.78M$ -2.78M$ -1.99M$ -1.21M
Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History

Cumberland Pharmaceuticals Debt to Assets

Cumberland Pharmaceuticals Cash Flow

Cumberland Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis